Published in PLoS Med on August 11, 2015
Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa? Curr HIV/AIDS Rep (2016) 0.86
Integrated HIV care and service engagement among people living with HIV who use drugs in a setting with a community-wide treatment as prevention initiative: a qualitative study in Vancouver, Canada. J Int AIDS Soc (2017) 0.76
Physician Decisions to Defer Antiretroviral Therapy in Key Populations: Implications for Reducing Human Immunodeficiency Virus Incidence and Mortality in Malaysia. Open Forum Infect Dis (2017) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88
Patient-centredness: a conceptual framework and review of the empirical literature. Soc Sci Med (2000) 12.87
Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med (2013) 5.39
Anthropology in the clinic: the problem of cultural competency and how to fix it. PLoS Med (2006) 4.37
From access to engagement: measuring retention in outpatient HIV clinical care. AIDS Patient Care STDS (2010) 3.03
Conspiracy beliefs about HIV are related to antiretroviral treatment nonadherence among african american men with HIV. J Acquir Immune Defic Syndr (2010) 2.05
Factors influencing physicians' judgments of adherence and treatment decisions for patients with HIV disease. Med Decis Making (2001) 1.97
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis (2011) 1.91
Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons. J Gen Intern Med (2001) 1.73
Forgiveness of non-adherence to HIV-1 antiretroviral therapy. J Antimicrob Chemother (2008) 1.70
Higher quality communication and relationships are associated with improved patient engagement in HIV care. J Acquir Immune Defic Syndr (2013) 1.35
Provider barriers to prescribing HAART to medically-eligible HIV-infected drug users. AIDS Care (2004) 1.32
Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. AIDS (2011) 1.06
Approaches to and outcomes of dyadic interview analysis. Qual Health Res (2010) 1.03
Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr (2012) 0.99
Discontinuation of antiretroviral therapy among adults receiving HIV care in the United States. J Acquir Immune Defic Syndr (2014) 0.95
Understanding treatment refusal among adults presenting for HIV-testing in Soweto, South Africa: a qualitative study. AIDS Behav (2015) 0.91
Readiness: the state of the science (or the lack thereof). Curr HIV/AIDS Rep (2010) 0.88
Individual variability in barriers affecting people's decision to take HAART: a qualitative study identifying barriers to being on HAART. AIDS Patient Care STDS (2006) 0.88
Challenges facing providers caring for HIV/HCV-coinfected patients. Qual Health Res (2011) 0.84